Axonal energy metabolism, and the effects in aging and neurodegenerative diseases

S Yang, JH Park, HC Lu - Molecular neurodegeneration, 2023 - Springer
Human studies consistently identify bioenergetic maladaptations in brains upon aging and
neurodegenerative disorders of aging (NDAs), such as Alzheimer's disease, Parkinson's …

Recent advances of nanomaterials for intervention in Parkinson's disease in the context of anti-inflammation

R Zhang, X Chen, Y Cheng, Z Chen, X Li… - Coordination Chemistry …, 2024 - Elsevier
Inflammation and neuroinflammation play critical roles in the pathogenesis of
neurodegenerative diseases such as Parkinson's disease (PD). Nanomaterials with reactive …

Glucocerebrosidase is imported into mitochondria and preserves complex I integrity and energy metabolism

P Baden, MJ Perez, H Raji, F Bertoli, S Kalb… - Nature …, 2023 - nature.com
Mutations in GBA1, the gene encoding the lysosomal enzyme β-glucocerebrosidase
(GCase), which cause Gaucher's disease, are the most frequent genetic risk factor for …

Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson's disease mouse model

TSZ Fang, Y Sun, AC Pearce, S Eleuteri… - Nature …, 2023 - nature.com
Mutations in SNCA, the gene encoding α-synuclein (αSyn), cause familial Parkinson's
disease (PD) and aberrant αSyn is a key pathological hallmark of idiopathic PD. This α …

Facilitating pro-survival mitophagy for alleviating Parkinson's disease via sequence-targeted lycopene nanodots

X Xia, H Li, X Xu, G Zhao, M Du - ACS nano, 2023 - ACS Publications
The pathogenesis of Parkinson's disease is closely linked to impaired mitochondrial function
and abnormal mitophagy. Biocompatible natural antioxidants effectively protect …

Characterization of pairs of toxic and nontoxic misfolded protein oligomers elucidates the structural determinants of oligomer toxicity in protein misfolding diseases

R Limbocker, N Cremades, R Cascella… - Accounts of Chemical …, 2023 - ACS Publications
Conspectus The aberrant misfolding and aggregation of peptides and proteins into amyloid
aggregates occurs in over 50 largely incurable protein misfolding diseases. These …

Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson's disease

AC Müller-Nedebock, MCJ Dekker, MJ Farrer… - npj Parkinson's …, 2023 - nature.com
The biological basis of the neurodegenerative movement disorder, Parkinson's disease
(PD), is still unclear despite it being 'discovered'over 200 years ago in Western Medicine …

Alpha synuclein: neurodegeneration and inflammation

G Forloni - International journal of molecular sciences, 2023 - mdpi.com
Alpha-Synuclein (α-Syn) is one of the most important molecules involved in the
pathogenesis of Parkinson's disease and related disorders, synucleinopathies, but also in …

[HTML][HTML] Role of autophagy pathway in Parkinson's disease and related Genetic Neurological disorders

C Themistokleous, E Bagnoli, R Parulekar… - Journal of molecular …, 2023 - Elsevier
The elucidation of the function of the PINK1 protein kinase and Parkin ubiquitin E3 ligase in
the elimination of damaged mitochondria by autophagy (mitophagy) has provided …

α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson's disease

FF Geibl, MT Henrich, Z Xie, E Zampese… - Molecular …, 2024 - Springer
Background Pathological accumulation of aggregated α-synuclein (aSYN) is a common
feature of Parkinson's disease (PD). However, the mechanisms by which intracellular aSYN …